Related Experiment Video
Updated: Dec 30, 2025

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
Obstructive Sleep Apnea, Hypertension, and Cardiovascular Risk: Epidemiology, Pathophysiology, and Management
Liann Abu Salman1, Rachel Shulman2, Jordana B Cohen3,4
1Department of Internal Medicine, Lankenau Medical Center, Wynnewood, PA, USA.
Purpose Of Review:
Given the rising prevalence of obstructive sleep apnea (OSA), we aimed to review the epidemiologic and pathophysiologic relationship of OSA, hypertension, and cardiovascular disease, and to summarize recent advances in the treatment of OSA.
Recent Findings:
OSA is associated with an elevated risk of hypertension and cardiovascular disease. Several pathophysiologic factors contribute to the relationship between OSA and vascular risk, including neurohormonal dysregulation, endothelial dysfunction, and inflammation. While CPAP reduces blood pressure, it has not been demonstrated to reduce cardiovascular risk. The combination of CPAP and weight loss has a synergistic effect on blood pressure and several metabolic parameters. Adherence to CPAP is poor across studies, potentially contributing to the attenuation of perceived cardiovascular benefit from CPAP therapy. A greater emphasis on adherence to CPAP and the combination of CPAP and weight loss are central to reducing cardiovascular risk among individuals with OSA.
More Related Videos
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Hypertension II: Pathophysiology
Hypertension and Regulation of Blood Pressure
Hypertension V: Nursing Management
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Coronary Artery Disease I: Introduction

